Skip to main content

Novel Rx

      RT @RHEUMarampa: Accdg to this study, no association was found between IFN levels and cognitive function in SLE pts (eve
      4 years ago
      Accdg to this study, no association was found between IFN levels and cognitive function in SLE pts (even after considering factors like SLE dse duration) Interesting! @RheumNow #ACR20 abs1788 @ZahiTouma https://t.co/F4j8H1CWJ9
      RT @ejdein1: Abst#L01. Pt is on MTX/ADA for RA and asks you about their COVID risk. What do you counsel your patient? #A
      4 years ago

      Abst#L01. Pt is on MTX/ADA for RA and asks you about their COVID risk. What do you counsel your patient? #ACR20 @RheumNow.

      RT @Janetbirdope: #osteoarthritis Rx with #tanezumab - analgesic or DMOAD? RCT in knee OA of 3021 pts & only 1312 co
      4 years ago
      #osteoarthritis Rx with #tanezumab - analgesic or DMOAD? RCT in knee OA of 3021 pts & only 1312 completed Rx. Tanezumab > improvement in pain v NSAIDs but NO diff in MCII and pt acceptable symptoms (PASS) over time #ACR20 #ACRbest abstr#1641 @RheumNow @CRASCRRheum https://t.co/x75ncz16uP
      ABCs of RA: Panel Discussion with Dr. Jonathan Kay

      They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.

      Roundtable on Gout: What's Hot at ACR 2020 with Gout Faculty

      Drs. Michael Pillinger, Naomi Schlesinger and Robert Keenan discuss the hot topics in Gout in a panel discussion at ACR 2020.

      Anakinra in Pediatric, Adult Still's Disease: Dr. Bella Mehta

      Dr. Bella Mehta reviews abstract #1633 at the 2020 ACR annual meeting. 

       

      RT @drpnash: Herpes Zoster Events with Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase 2 and Ph
      4 years ago
      Herpes Zoster Events with Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase 2 and Phase 3 Trials https://t.co/70oOHXihFb #SLE #zoster x 4-5 times increase in zoster
      RT @drdavidliew: How do we dose maintenance rituximab in AAV to optimise B cell depletion but minimise hypogammaglob?

      D
      4 years ago
      How do we dose maintenance rituximab in AAV to optimise B cell depletion but minimise hypogammaglob? Drug levels may be the answer. In this cohort (n=61) trough >550ng/mL: all B cell depleted >1000ng/mL: all got hypogammaglob very interesting concept! #ACR20 ABST1438 @RheumNow https://t.co/0pcl0BW2Tv
      RT @RHEUMarampa: Data from BIOBADASER 3 showed that there was a ⬇ in the incidence of S. pneumonia-related infxns in R
      4 years ago
      Data from BIOBADASER 3 showed that there was a ⬇ in the incidence of S. pneumonia-related infxns in RA pts on b/tsDMARD after receiving the stepwise combined vax scheme (conj+PS) @RheumNow #ACR20 abs1465 #VaccinesWork https://t.co/KlestmKfaO